- The new rhododendron cultivars, Xilinmen and Jiaoyan were sold to Yunnan Green-Land Biological Technology Co., Ltd. at price of RMB 300 thousand yuan.
- Crude medicine of cepharanthine hydrochloride and approval document for clinical trials of cepharanthine hydrochloride injection were sold to Dali Pharmaceutical Co.,Ltd. at price of RMB six million.
- The intellectual property and relative achievements of traditional Chinese medicine SH were transferred to Yunnan SH-IDEA Pharmaceutical Company Ltd.
- The anti-tumor drugs, extracts of hop (fifth category of new drugs) were transferred to Shanghai Sine Promod Pharmaceutical Co., Ltd.